Cite
MLA Citation
Seung-Woo Hong et al.. “Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway.” Lung cancer, vol. 106, 2017, pp. 115–124. http://access.bl.uk/ark:/81055/vdc_100045084215.0x000031